InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
63,739.07
(
-0.79%
)
Post# of 252308
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: ghmm post# 214947

Friday, 11/10/2017 3:32:30 PM

Friday, November 10, 2017 3:32:30 PM

Post# of 252308
NKTR

A couple of the posters are out.
http://www.nektar.com/application/files/1315/1033/7352/NKTR-214__2017SITC_Poster-P77.pdf

Here is a very interesting one NKTR-262 (TLR agonist) + NKTR-214
The mouse model they injected just 1 tumor with one dose of 262 and then NKTR-214. They've said they intend to file IND in 2017 still.
http://www.nektar.com/application/files/8015/1033/6150/NKTR-262-NKTR-214__2017SITC_Poster-P275.pdf.pdf

For those interested again the presentation is 6:15pm (ET) tomorrow webcast is (Not sure if all of it will be on the PIVOT-02 full data or they'll talk about the preclinical stuff too):
https://edge.media-server.com/m6/p/cn2rdud9
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up